On June 20-22, 2022, Celon Pharma will take part in the international conference “Prespective Solutions for Biotechnological Medicine”, the main assumption of which will be to focus attention on the need to improve the methodology of allocation and accounting for European funds allocated to the development of research and innovative implementations, on the initiative of the European Commission.
As part of the conference, Celon Pharma will have its own session in which the company’s achievements in the field of RD will be presented and a discussion panel with the participation of representatives of the medical biotechnology industry. The conference will take the form of an international meeting of industry managers, technologists and scientists under the name “Central European Technology Forum CETEF’22”, with the participation of stakeholders from 16 Central European countries and the leadership of the innovation and research division of the European Commission.<\/p>\n","protected":false},"excerpt":{"rendered":"